Unicycive Therapeutics reports $61.4M cash balance as of June 30, 2026

Unicycive Therapeutics reported an ending cash balance of approximately $61.4 million as of June 30, 2026.Key Highlights:Original SEC Filing: Unicycive Therapeutics, Inc. [ UNCY ] - 8-K - Jul. 02, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important informati…

Unicycive Therapeutics reported an ending cash balance of approximately $61.4 million as of June 30, 2026.

Key Highlights:

Company reported preliminary cash balance of ~$61.4M at June 30, 2026, indicating available liquidity.
Results are preliminary and prepared by management, not audited or reviewed by independent accountants.
Independent auditors have not performed procedures or provided any assurance on these preliminary figures.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.